245 related articles for article (PubMed ID: 27356823)
61. Evaluation of Non-alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse Imaging Elastography in Rat Models.
Guo Y; Dong C; Lin H; Zhang X; Wen H; Shen Y; Wang T; Chen S; Liu Y; Chen X
Ultrasound Med Biol; 2017 Nov; 43(11):2619-2628. PubMed ID: 28811064
[TBL] [Abstract][Full Text] [Related]
62. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data.
Andersen G; Plum-Mörschel L; Hockings PD; Morsing A; Palle MS; Svolgaard O; Flint A
Adv Ther; 2020 Dec; 37(12):4866-4876. PubMed ID: 33006125
[TBL] [Abstract][Full Text] [Related]
63. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
Castera L
Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
[TBL] [Abstract][Full Text] [Related]
64. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.
Ichikawa S; Motosugi U; Morisaka H; Sano K; Ichikawa T; Enomoto N; Matsuda M; Fujii H; Onishi H
J Magn Reson Imaging; 2015 Jul; 42(1):204-10. PubMed ID: 25223820
[TBL] [Abstract][Full Text] [Related]
65. MR Elastography: Practical Questions, From the
Yin M; Ehman RL
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329437. PubMed ID: 37162036
[TBL] [Abstract][Full Text] [Related]
66. Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis.
Rosso C; Caviglia GP; Abate ML; Vanni E; Mezzabotta L; Touscoz GA; Olivero A; Marengo A; Rizzetto M; Bugianesi E; Smedile A
Dig Liver Dis; 2016 Jan; 48(1):55-61. PubMed ID: 26514735
[TBL] [Abstract][Full Text] [Related]
67. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.
Moustafa EF; Makhlouf N; Hassany SM; Helmy A; Nasr A; Othman M; Seif H; Darwish M; Hassan H; Hessen M
Arab J Gastroenterol; 2017 Mar; 18(1):6-12. PubMed ID: 28262531
[TBL] [Abstract][Full Text] [Related]
68. Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography.
Venkatesh SK; Yin M; Takahashi N; Glockner JF; Talwalkar JA; Ehman RL
Abdom Imaging; 2015 Apr; 40(4):766-75. PubMed ID: 25805619
[TBL] [Abstract][Full Text] [Related]
69. Quantitative 3D magnetic resonance elastography: Comparison with dynamic mechanical analysis.
Arunachalam SP; Rossman PJ; Arani A; Lake DS; Glaser KJ; Trzasko JD; Manduca A; McGee KP; Ehman RL; Araoz PA
Magn Reson Med; 2017 Mar; 77(3):1184-1192. PubMed ID: 27016276
[TBL] [Abstract][Full Text] [Related]
70. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Ajmera V; Liu A; Bettencourt R; Dhar D; Richards L; Loomba R
Aliment Pharmacol Ther; 2021 Jul; 54(1):68-77. PubMed ID: 33975381
[TBL] [Abstract][Full Text] [Related]
71. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
72. MRE in NAFLD: Promising but Further Validation is Required.
Ryan JD; Tsochatzis EA
Ann Hepatol; 2017; 16(3):331-332. PubMed ID: 28425401
[TBL] [Abstract][Full Text] [Related]
73. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
[TBL] [Abstract][Full Text] [Related]
74. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease.
Mansoor S; Collyer E; Alkhouri N
Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832
[TBL] [Abstract][Full Text] [Related]
75. Combinational elastography for assessment of liver fibrosis in patients with liver injury.
Yazaki T; Tobita H; Sato S; Miyake T; Kataoka M; Ishihara S
J Int Med Res; 2022 Jun; 50(6):3000605221100126. PubMed ID: 35735003
[TBL] [Abstract][Full Text] [Related]
76. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
[TBL] [Abstract][Full Text] [Related]
77. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
78. A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient.
Winters AC; Mittal R; Schiano TD
Clin Transplant; 2019 Oct; 33(10):e13700. PubMed ID: 31441967
[TBL] [Abstract][Full Text] [Related]
79. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
[TBL] [Abstract][Full Text] [Related]
80. Which are the cut-off values of 2D-Shear Wave Elastography (2D-SWE) liver stiffness measurements predicting different stages of liver fibrosis, considering Transient Elastography (TE) as the reference method?
Sporea I; Bota S; Gradinaru-Taşcău O; Sirli R; Popescu A; Jurchiş A
Eur J Radiol; 2014 Mar; 83(3):e118-22. PubMed ID: 24380640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
